Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults
- 7 July 2010
- Vol. 28 (38) , 6367-6373
- https://doi.org/10.1016/j.vaccine.2010.06.084
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Characterization of Antibodies Induced by Vaccination with Hepatitis C Virus Envelope GlycoproteinsThe Journal of Infectious Diseases, 2010
- MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly AdultsPLOS ONE, 2009
- Coexpression of Hepatitis C Virus E1 and E2 Chimeric Envelope Glycoproteins Displays Separable Ligand Sensitivity and Increases Pseudotype Infectious TiterJournal of Virology, 2004
- Simultaneous Detection of 15 Human Cytokines in a Single Sample of Stimulated Peripheral Blood Mononuclear CellsClinical and Vaccine Immunology, 2003
- Quasispecies of Hepatitis C Virus and Genetic Drift of the Hypervariable Region in Chronic Type C HepatitisThe Journal of Infectious Diseases, 1995
- Long interval between HCV infection and development of hepatocellular carcinomaLiver International, 1995
- Hepatitis C virus and hepatocellualr carcinomaFEMS Microbiology Reviews, 1994
- Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic infectionHepatology, 1993
- Marked sequence diversity in the putative envelope proteins of hepatitis C virusesVirus Research, 1992
- Hepatitis C virus antibody in hepatocellular carcinoma in TaiwanJournal of Medical Virology, 1991